Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 979237, 4 pages
http://dx.doi.org/10.1155/2015/979237
Case Report

Variant Guillain-Barré Syndrome in a Patient with Non-Hodgkin’s Lymphoma

1St George Hospital, Kogarah, Sydney, NSW 2217, Australia
2Shoalhaven District Memorial Hospital, Nowra, NSW 2541, Australia
3Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia

Received 18 March 2015; Revised 5 July 2015; Accepted 3 August 2015

Academic Editor: Kostas Konstantopoulos

Copyright © 2015 R. H. Bishay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Seffo and H. A. Daw, “Non-hodgkin lymphoma and Guillain-Barré syndrome: a rare association,” Clinical Advances in Hematology and Oncology, vol. 8, no. 3, pp. 201–203, 2010. View at Google Scholar · View at Scopus
  2. P. Giglio and M. R. Gilbert, “Neurologic complications of non-Hodgkin's lymphoma,” Current Hematologic Malignancy Reports, vol. 1, no. 4, pp. 214–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Re, A. Schwenk, P. Hegener, S. Bamborschke, V. Diehl, and H. Tesch, “Guillain-Barre syndrome in a patient with non-Hodgkin's lymphoma,” Annals of Oncology, vol. 11, no. 2, pp. 217–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Huynh and M. C. Kiernan, “Nerve conduction studies,” Australian Family Physician, vol. 40, no. 9, pp. 693–697, 2011. View at Google Scholar · View at Scopus
  5. R. A. C. Hughes and D. R. Cornblath, “Guillain-Barré syndrome,” The Lancet, vol. 366, no. 9497, pp. 1653–1666, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Wanschitz, W. Dichtl, H. Budka, W. N. Löscher, and S. Boesch, “Acute motor and sensory axonal neuropathy in Burkitt-like lymphoma,” Muscle & Nerve, vol. 34, no. 4, pp. 494–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Terenghi, G. Ardolino, and E. Nobile-Orazio, “Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-Hodgkin lymphoma,” Journal of the Peripheral Nervous System, vol. 12, no. 2, pp. 142–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Carmona, J. D. Alonso, M. de las Heras, and A. Navarrete, “Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyound anecdotal evidence?” Clinical & Translational Oncology, vol. 8, no. 10, pp. 764–766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Magné, C. Foa, P. Castadot, J. Otto, I. Birtwisle-Peyrottes, and A. Thyss, “Guillain-Barré syndrome and non-Hodgkin's lymphoma. Report of one case and review of literature,” Revue Medicale de Bruxelles, vol. 26, no. 2, pp. 108–111, 2005. View at Google Scholar · View at Scopus
  10. A. Toren, M. Mandel, E. Shahar et al., “Primary central nervous system Burkitt's lymphoma presenting as Guillain-Barre syndrome,” Medical and Pediatric Oncology, vol. 23, no. 4, pp. 372–375, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Usmani, R. Bhatia, O. F. Ikpatt, and K. R. Sharma, “Diffuse large B-cell lymphoma presenting as miller fisher syndrome,” Muscle & Nerve, vol. 45, no. 1, pp. 138–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Kalita, U. K. Misra, G. Goyal, and M. Das, “Guillain-Barré syndrome: subtypes and predictors of outcome from India,” Journal of the Peripheral Nervous System, vol. 19, no. 1, pp. 36–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-C. Vigliani, M. Magistrello, P. Polo, R. Mutani, and A. Chiò, “Risk of cancer in patients with Guillain-Barre syndrome (GBS). A population-based study,” Journal of Neurology, vol. 251, no. 3, pp. 321–326, 2004. View at Publisher · View at Google Scholar
  14. M. Wada, K. Kurita, K. Tajima, T. Kawanami, and T. Kato, “A case of inflammatory demyelinating polyradiculoneuropathy associated with T-cell lymphoma,” Acta Neurologica Scandinavica, vol. 107, no. 1, pp. 62–66, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Myers and S. F. Williams, “Guillain-Barre syndrome after autologous bone marrow transplantation for breast cancer: report of two cases,” Bone Marrow Transplantation, vol. 13, no. 3, pp. 341–344, 1994. View at Google Scholar · View at Scopus
  16. D. Maimone, P. Annunziata, I. L. Simone, P. Livrea, and G. C. Guazzi, “Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy,” Journal of Neuroimmunology, vol. 47, no. 1, pp. 55–61, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Forsyth, J. Dalmau, F. Graus, V. Cwik, M. K. Rosenblum, and J. B. Posner, “Motor neuron syndromes in cancer patients,” Annals of Neurology, vol. 41, no. 6, pp. 722–730, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. G. J. Hankey, “Guillain-Barre syndrome in western Australia, 1980–1985,” Medical Journal of Australia, vol. 146, no. 3, pp. 130–133, 1987. View at Google Scholar · View at Scopus
  19. J. Halls, C. Bredkjaer, and M. L. Friis, “Guillain-Barre syndrome: diagnostic criteria, epidemiology, clinical course and prognosis,” Acta Neurologica Scandinavica, vol. 78, no. 2, pp. 118–122, 1988. View at Publisher · View at Google Scholar · View at Scopus